Why Insys Therapeutics Fell More than 70%
Yesterday
More
Why Insys Therapeutics Fell
More than 70% YesterdayLiquidity positionIn its first-quarter
earnings press release, which it published on May 10, Insys
Therapeutics (INSY) highlighted the possibility of its being unable
to continue as a going concern.